China Medical & HealthCare Group Limited provided unaudited consolidated guidance for the five months ended May 31, 2022. For the period, the Group is expected to record a Net Loss for the five months ended 31 May 2022 which represents an approximately 316% increase as compared with the Net Loss for the corresponding period in 2021; an approximately 40% to 50% decrease, when compared with the Net Loss for the six months, ended 30 June 2021; or an approximately 77% to 87% increase, when compared with the Net Loss for the six months, ended 30 June 2021 excluding the one-off non-recurring item of impairment loss recognized on loan receivable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 HKD | 0.00% |
|
0.00% | -13.75% |
05-20 | Tian an Medicare Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
05-02 | China Medical & HealthCare Changes Name to Tian An Medicare | MT |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 95.97M | |
-29.52% | 14.76B | |
+3.48% | 11.75B | |
-7.21% | 11.48B | |
+8.23% | 10.76B | |
+27.94% | 8.6B | |
-6.41% | 7.45B | |
+8.01% | 6.84B | |
+9.84% | 6.48B | |
+16.78% | 4.47B |
- Stock Market
- Equities
- 383 Stock
- News Tian An Medicare Limited
- China Medical & HealthCare Group Limited Provides Unaudited Consolidated Guidance for the Five Months Ended May 31, 2022